ArticleTherapeutic advances in medical oncology2020

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with

Antonio Avallone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.